A defect in platelet aggregation in Bartter's syndrome
- 1 February 1980
- journal article
- research article
- Published by Elsevier in The American Journal of Medicine
- Vol. 68 (2) , 171-180
- https://doi.org/10.1016/0002-9343(80)90351-4
Abstract
No abstract availableThis publication has 33 references indexed in Scilit:
- Bartter's Syndrome: Urinary Prostaglandin E-like Material and Kallikrein; Indomethacin EffectsAnnals of Internal Medicine, 1977
- Bartter's Syndrome Results from an Imbalance of Vasoactive HormonesAnnals of Internal Medicine, 1977
- HUMAN ARTERIAL AND VENOUS TISSUES GENERATE PROSTACYCLIN (PROSTAGLANDIN X), A POTENT INHIBITOR OF PLATELET AGGREGATIONThe Lancet, 1977
- Bartter's syndrome: A disorder characterized by high urinary prostaglandins and a dependence of hyperreninemia on prostaglandin synthesisThe American Journal of Medicine, 1976
- Role of prostaglandins in the pathogenesis of Bartter's syndromeThe American Journal of Medicine, 1976
- Bartter's syndrome with hyperplasia of renomedullary cells: Successful treatment with indomethacinKidney International, 1976
- Urinary prostaglandins. Identification and origin.Journal of Clinical Investigation, 1975
- Prostaglandin D2 inhibits the aggregation of human plateletsThrombosis Research, 1974
- Relative activity of prostaglandins E1, A1, E2 and A2 on lipolysis, platelet aggregation, smooth muscle and the cardiovascular systemJournal of Pharmacy and Pharmacology, 1969
- Hyperplasia of the juxtaglomerular complex with hyperaldosteronism and hypokalemic alkalosisThe American Journal of Medicine, 1962